Dries Reynders

Journal Article
A1
open access

Evaluation of a rapid lateral flow assay for the detection of taeniosis and cysticercosis at district hospital level in Tanzania : a prospective multicentre diagnostic accuracy study

Inge Van Damme (UGent) , Chiara Trevisan (UGent) , Mwemezi Kabululu, Dominik Stelzle, Charles E. Makasi, Veronika Schmidt-Urbaneja, Kabemba E. Mwape, Chishimba Mubanga, Gideon Zulu, Karen Shou Møller, et al.

(2025) PLOS NEGLECTED TROPICAL DISEASES. 19(3).

Add to list

Journal Article
A1
open access

Factors associated with statural growth in pediatric kidney transplant recipients with focus on metabolic acidosis

Agnieszka Prytula-Ebels (UGent) , Dries Reynders (UGent) , Els Goetghebeur (UGent) , Kai Krupka, Justine Bacchetta, Nele Kanzelmeyer, Isabella Guzzo, Raffaella Labbadia, Elisa Benetti, Mohan Shenoy, et al.

(2025) PEDIATRIC NEPHROLOGY. 40(6). p.2059-2070

Add to list

Miscellaneous
open access

Budget impact projections for pharmaceuticals

Irina Odnoletkova, Dries Reynders (UGent) , Frederik De Keersmaeker (UGent) , Stephan Devriese, Els Goetghebeur (UGent) and Irina Cleemput

(2024) KCE Report. In KCE Reports Health Technology Assessment 381.

Add to list

Journal Article
A1
open access

The role of the estimand framework in the analysis of patient-reported outcomes in single-arm trials: a case study in oncology

Doranne Thomassen, Satrajit Roychoudhury, Cecilie Delphin Amdal, Dries Reynders (UGent) , Jammbe Z. Musoro, Willi Sauerbrei, Els Goetghebeur (UGent) , Saskia le Cessie (UGent) and [ missing ] on behalf of the SISAQOL-IMI Work Package 3

(2024) BMC MEDICAL RESEARCH METHODOLOGY. 24(1).

Add to list

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

Piet Ost (UGent) , Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, François-Xavier Otte, Alfonso Gomez-Iturriaga, Wouter Everaerts, Mohamed Shelan, Antonio Conde-Moreno, et al.

(2024) EUROPEAN UROLOGY ONCOLOGY. 7(3). p.462-468

Add to list

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Mathieu Spaas (UGent) , Nora Sundahl, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) , Fréderic Duprez (UGent) , Yolande Lievens (UGent) , Veerle Surmont (UGent) , Lieve Brochez (UGent) , Dries Reynders (UGent) , et al.

(2023) JAMA ONCOLOGY. 9(9). p.1205-1213

Add to list

PEACE V - STORM randomized phase II trial for oligorecurrent nodal prostate cancer : acute toxicity

T. Zilli, S. Siva, R. Heikkila, P. Dirix, N. Liefhooghe, F. Otte, A. Gomez-Iturriaga, W. Everaerts, M. Shelan, A. Conde-Moreno, et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 170(S1). p.S528-S529

Add to list

Journal Article
A1
open access

Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases

Wim Ceelen (UGent) , Louis Sandra, Leen Van de Sande (UGent) , M Graversen, MB Mortensen, An Vermeulen (UGent) , Elke Gasthuys (UGent) , Dries Reynders (UGent) , Sarah Cosyns (UGent) , Anne Hoorens (UGent) , et al.

(2022) EBIOMEDICINE. 82.

Add to list

Miscellaneous
open access

The multicenter, randomized, phase 2 PEACE V-STORM trial : defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases

Thomas Zilli, Piet Dirix, Reino Heikkila, Nick Liefhooghe, Shankar Siva, Alfonso Gomez-Iturriaga, Wouter Everaerts, Francois Otte, Mohamed Shelan, Carole Mercier, et al.

(2021) EUROPEAN UROLOGY FOCUS. 7(2). p.241-244

Add to list

Prognostic value of high-risk human papillomavirus DNA and p16(INK4)(a) immunohistochemistry in patients with anal cancer : an individual patient data meta-analysis

Theresa Obermueller, Joris Hautekiet, Maria Paula Busto, Dries Reynders (UGent) , Liliana Belgioia, Annemieke Cats, Duncan C. Gilbert, Stefan A. Koerber, Sabine Mai, Didier Meulendijks, et al.

(2021) EUROPEAN JOURNAL OF CANCER. 157. p.165-178

Academic Bibliography

Dries Reynders

Evaluation of a rapid lateral flow assay for the detection of taeniosis and cysticercosis at district hospital level in Tanzania : a prospective multicentre diagnostic accuracy study

Factors associated with statural growth in pediatric kidney transplant recipients with focus on metabolic acidosis

Budget impact projections for pharmaceuticals

The role of the estimand framework in the analysis of patient-reported outcomes in single-arm trials: a case study in oncology

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

PEACE V - STORM randomized phase II trial for oligorecurrent nodal prostate cancer : acute toxicity

Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases

The multicenter, randomized, phase 2 PEACE V-STORM trial : defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases

Prognostic value of high-risk human papillomavirus DNA and p16(INK4)(a) immunohistochemistry in patients with anal cancer : an individual patient data meta-analysis

Contents

Support

Contact